A prometabolite strategy inhibits cardiometabolic disease in an ApoE–/– murine model of atherosclerosis
Butyrate, a microbiome-derived short-chain fatty acid with pleiotropic effects on inflammation and metabolism, has been shown to significantly reduce atherosclerotic lesions, rectify routine metabolic parameters such as low-density lipoprotein cholesterol (LDL-C), and reduce systemic inflammation in...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
American Society for Clinical investigation
2025-08-01
|
| Серія: | JCI Insight |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1172/jci.insight.191090 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|